References
- Swerdlow, S.H., E. Campo, S. A. Pileri, et al. 2016. The 2016 revision
of the World Health Organization classification of lymphoid neoplasms.
Blood 127(20):2375-2390.
- Lachenal, F., F. Berger, H. Ghesquières, et al. 2007.
Angioimmunoblastic T-cell lymphoma: clinical and laboratory features
at diagnosis in 77 patients. Medicine (Baltimore) 86(5):282-292.
- Xie, C., X. Li, H. Zeng, and W. Qian. 2020. Molecular insights
into pathogenesis and targeted therapy of peripheral T cell lymphoma.
Exp Hematol Oncol 9(1):30.
- Botros, N., L. Cerroni, A. Shawwa, et al. 2015. Cutaneous
manifestations of angioimmunoblastic T-cell lymphoma: clinical and
pathological characteristics. Am J Dermatopathol 37(4):274–283.
- Lunning, M. A., and J. M. Vose. 2017. Angioimmunoblastic T-cell
lymphoma: the many-faced lymphoma. Blood 129(9):1095-1102.
- Rodríguez-Cortés, J., and T. Palomero. 2016. The curious origins of
angioimmunoblastic T-cell lymphoma. Curr Opin Hematol 23(4):434-443.
- de Leval, L., D. S. Rickman, C. Thielen, et al. 2007. The gene
expression profile of nodal peripheral T-cell lymphoma demonstrates a
molecular link between angioimmunoblastic T-cell lymphoma (AITL) and
follicular helper T (TFH) cells. Blood 109(11):4952-4963.
- Grogg, K. L., A. D. Attygale, W. R. Macon, E. D. Remstein, P. J.
Kurtin, and A. Dogan. 2006. Expression of CXCL13, a chemokine highly
upregulated in germinal center T-helper cells, distinguishes
angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma,
unspecified. Mod Pathol 19(8):1101-1107.
- Hopfinger, G., and P. Staber. 2019. Current standard in diagnostic and
therapy of peripheral T-cell lymphoma. Dtsch Med Wochenschr
144(20):1400-1404.
- Dunleavy, K., H. W. Wilson, and E. S. Jaffe. 2007. Angioimmunoblastic
T cell lymphoma: pathobiological insights and clinical implications.
Curr Opin Hematol 14(4):348–353.
- Laforga, J. B., J. M. Gasent, and M. Vaquero. 2010. Potential
misdiagnosis of angioimmunoblastic T-cell lymphoma with Hodgkin’s
lymphoma: a case report. Acta Cytol 54(5):840-844.
- Gao, X., W. Huang, W. Li, J. Xie, Y. Zheng, and X. Zhou. 2015.
Clinicopathologic analysis of angioimmunoblastic T-cell lymphoma with
Hodgkin/Reed-Sternberg-like cells. Chin J Pathol 8(44):553-558.
- Parekh, V., and D. Peker. 2015. EBV-related primary splenic
lymphocyte-depleted classical Hodgkin lymphoma. J Clin Pathol
68(11):947-950.
- Ferrarini, I., A. Rigo, C. Visco, M. Krampera, and F. Vinante. 2020.
The evolving knowledge on T and NK cells in classic Hodgkin lymphoma:
insights into novel subsets populating the immune microenvironment.
Cancers (Basel) 12(12):3757.
- Connors, J. M. 2020. Hodgkin lymphoma: outsmarting HRS cells. Blood
136(21):2362-2364.
- Moccia, A. A., S. Aeppli, S. Güsewell, et al. 2021. Clinical
characteristics and outcome of patients over 60 years with Hodgkin
lymphoma treated in Switzerland. Hematol Oncol 39(2):196-204.